Long-term survival rates for immunotherapies could be misinterpreted

Designing better antibody drugs with artificial intelligence
15 April 2021
Mathematical method builds synthetic hearts to identify how heart shape could be linked to disease
15 April 2021

Long-term survival rates for immunotherapies could be misinterpreted

Immune checkpoint inhibitors have transformed cancer care to the point where the popular Cox proportional-hazards model provides misleading estimates of the treatment effect, according to a new study published April 15 in JAMA Oncology.

Comments are closed.